Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
Osteogenesis imperfecta (OI) is a genetic bone pathology with prenatal onset, characterized by brittle bones in response to abnormal collagen composition. There is presently no cure for OI. We previously showed that human first trimester fetal blood mesenchymal stem cells (MSCs) transplanted into a...
المؤلفون الرئيسيون: | Jones, G, Moschidou, D, Abdulrazzak, H, Kalirai, B, Vanleene, M, Osatis, S, Shefelbine, S, Horwood, N, Marenzana, M, De Coppi, P, Bassett, J, Williams, G, Fisk, N, Guillot, P |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
2014
|
مواد مشابهة
-
Ontological differences in first compared to third trimester human fetal placental chorionic stem cells
حسب: Jones, G, وآخرون
منشور في: (2012) -
Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.
حسب: Vanleene, M, وآخرون
منشور في: (2011) -
Ontological differences in first compared to third trimester human fetal placental chorionic stem cells.
حسب: Gemma N Jones, وآخرون
منشور في: (2012-01-01) -
Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.
حسب: Guillot, P, وآخرون
منشور في: (2008) -
Structure–mechanics relationships of collagen fibrils in the osteogenesis imperfecta mouse model
حسب: Andriotis, O. G., وآخرون
منشور في: (2016)